The 4M€ invested in this round of funding will enable the acceleration of the commercial development of the core product CLARK, a connected AED defibrillator.
Cardiac arrests happen when least expected, family, friends or anyone can help increase the chance of survival if they can access a simple and easy to use defibrillator. In France alone, each year, more than 50,000 people die prematurely from cardiac arrest. Thousands of lives can be saved if intervention takes place in the first 4 minutes.
CLARK is designed to be as light and easy to use as possible, the core differentiation of the product is that it is smart and connected and can be tested and upgraded remotely. The company sells and rents defibrillators to multiple segments not only corporates or venues that are compelled to have one by regulation, but also individuals and sme’s with a view to significantly increase the availability of AED’s where they are the most needed.
The company also develops First Aid contents and courses to increase global awareness around life saving rules and actions, via the app “Everyday Heroes”.
The company and its mission is a very good example of our impact investing strategy and well aligned with Mutuelles Impact investment thesis in the field of health and prevention. We at Xange are historically active in the field of impact investing and are proud to manage the fund Mutuelles Impact, launched by the federation La Mutualité Française in partnership with Investir&+ and backed by 45 Mutuelles
